Regulus Therapeutics Inc (RGLS)
2.22
-0.13
(-5.53%)
USD |
NASDAQ |
Apr 18, 16:00
2.22
0.00 (0.00%)
After-Hours: 20:00
Regulus Therapeutics Total Assets (Quarterly): 30.75M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 30.75M |
| September 30, 2023 | 37.75M |
| June 30, 2023 | 43.65M |
| March 31, 2023 | 37.02M |
| December 31, 2022 | 46.72M |
| September 30, 2022 | 52.13M |
| June 30, 2022 | 54.30M |
| March 31, 2022 | 60.98M |
| December 31, 2021 | 68.45M |
| September 30, 2021 | 43.04M |
| June 30, 2021 | 49.52M |
| March 31, 2021 | 39.84M |
| December 31, 2020 | 37.60M |
| September 30, 2020 | 27.34M |
| June 30, 2020 | 29.78M |
| March 31, 2020 | 35.01M |
| December 31, 2019 | 42.08M |
| September 30, 2019 | 21.41M |
| June 30, 2019 | 25.69M |
| March 31, 2019 | 19.88M |
| December 31, 2018 | 27.93M |
| September 30, 2018 | 34.77M |
| June 30, 2018 | 49.17M |
| March 31, 2018 | 62.08M |
| Date | Value |
|---|---|
| December 31, 2017 | 77.81M |
| September 30, 2017 | 90.85M |
| June 30, 2017 | 61.86M |
| March 31, 2017 | 80.17M |
| December 31, 2016 | 100.66M |
| September 30, 2016 | 116.27M |
| June 30, 2016 | 129.93M |
| March 31, 2016 | 128.14M |
| December 31, 2015 | 141.08M |
| September 30, 2015 | 143.45M |
| June 30, 2015 | 150.26M |
| March 31, 2015 | 164.85M |
| December 31, 2014 | 171.48M |
| September 30, 2014 | 104.02M |
| June 30, 2014 | 113.92M |
| March 31, 2014 | 124.11M |
| December 31, 2013 | 123.06M |
| September 30, 2013 | 130.59M |
| June 30, 2013 | 92.52M |
| March 31, 2013 | 97.03M |
| December 31, 2012 | 103.52M |
| September 30, 2012 | 40.72M |
| June 30, 2012 | 33.19M |
| December 31, 2011 | 42.88M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
21.41M
Minimum
Sep 2019
68.45M
Maximum
Dec 2021
41.21M
Average
39.84M
Median
Mar 2021
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals Inc | 748.96M |
| ADMA Biologics Inc | 329.18M |
| FibroGen Inc | 423.53M |
| Protara Therapeutics Inc | 78.95M |
| Amylyx Pharmaceuticals Inc | 517.45M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 9.563M |
| Shareholders Equity (Quarterly) | 21.19M |